Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaweh Shakery

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|October 3, 2009
[Psoriasis--clinical picture and current therapy]Kaweh Shakery, Kristian Reich
American Journal of Clinical Dermatology|November 24, 2004
Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate (Copaxone) injection for the treatment of multiple sclerosisNoemi Soós, Kaweh Shakery, Ulrich Mrowietz
Clinical, Cosmetic and Investigational Dermatology|September 22, 2017
An empirically generated responder definition for rosacea treatmentGerald Staedtler, Kaweh Shakery, Jan Endrikat, et al.
Cutis|November 5, 2016
Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trialJames A Solomon, Stephen Tyring, Gerald Staedtler, et al.
Critical Care Explorations|August 22, 2024
Understanding Causes of Death in Patients With Acute Respiratory Distress Syndrome: A Narrative ReviewSusan E Bromley, Kaweh Shakery, Pareen Vora, et al.
Cutis|November 23, 2016
Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trialStephen Tyring, James A Solomon, Gerald Staedtler, et al.
Cutis|August 6, 2015
A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosaceaZoe Diana Draelos, Boni E Elewski, Julie C Harper, et al.
Skin Pharmacology and Physiology|April 14, 2017
Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference DrugsWalter Wigger-Alberti, Ragna Williams, Yi-Ling von Mackensen, et al.
Dermatology and Therapy|September 4, 2025
Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized StudyStefan J Jodl, Margitta Worm, Frauke Friedrichs, et al.
Critical Care (London, England)|October 23, 2025
Safety and efficacy of inhaled PEG-ADM in ARDS patients: a randomised controlled trialChristian Karagiannidis, Danny F McAuley, B Taylor Thompson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Medizinische Monatsschrift Fur Pharmazeuten|October 3, 2009
[Psoriasis--clinical picture and current therapy]Kaweh Shakery, Kristian Reich
American Journal of Clinical Dermatology|November 24, 2004
Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate (Copaxone) injection for the treatment of multiple sclerosisNoemi Soós, Kaweh Shakery, Ulrich Mrowietz
Clinical, Cosmetic and Investigational Dermatology|September 22, 2017
An empirically generated responder definition for rosacea treatmentGerald Staedtler, Kaweh Shakery, Jan Endrikat, et al.
Cutis|November 5, 2016
Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trialJames A Solomon, Stephen Tyring, Gerald Staedtler, et al.
Critical Care Explorations|August 22, 2024
Understanding Causes of Death in Patients With Acute Respiratory Distress Syndrome: A Narrative ReviewSusan E Bromley, Kaweh Shakery, Pareen Vora, et al.
Cutis|November 23, 2016
Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trialStephen Tyring, James A Solomon, Gerald Staedtler, et al.
Cutis|August 6, 2015
A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosaceaZoe Diana Draelos, Boni E Elewski, Julie C Harper, et al.
Skin Pharmacology and Physiology|April 14, 2017
Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference DrugsWalter Wigger-Alberti, Ragna Williams, Yi-Ling von Mackensen, et al.
Dermatology and Therapy|September 4, 2025
Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized StudyStefan J Jodl, Margitta Worm, Frauke Friedrichs, et al.
Critical Care (London, England)|October 23, 2025
Safety and efficacy of inhaled PEG-ADM in ARDS patients: a randomised controlled trialChristian Karagiannidis, Danny F McAuley, B Taylor Thompson, et al.
Pageof 1